These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 28356124

  • 1. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S, Kager L, Danielyan S, Avagyan A, Karamyan N, Vardevanyan H, Mkhitaryan S, Papyan R, Zohrabyan D, Safaryan L, Sargsyan L, Harutyunyan L, Hakobyan L, Iskanyan S, Tamamyan G.
    Ital J Pediatr; 2017 Mar 29; 43(1):32. PubMed ID: 28356124
    [Abstract] [Full Text] [Related]

  • 2. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan 29; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

  • 3. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA.
    Hum Pathol; 2017 May 29; 63():89-97. PubMed ID: 28235628
    [Abstract] [Full Text] [Related]

  • 4. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E.
    Spine J; 2014 Jul 01; 14(7):e15-21. PubMed ID: 24534393
    [Abstract] [Full Text] [Related]

  • 5. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
    Matcuk GR, Patel DB, Schein AJ, White EA, Menendez LR.
    Skeletal Radiol; 2015 Jul 01; 44(7):1027-31. PubMed ID: 25712768
    [Abstract] [Full Text] [Related]

  • 6. RANKL, denosumab, and giant cell tumor of bone.
    Thomas DM.
    Curr Opin Oncol; 2012 Jul 01; 24(4):397-403. PubMed ID: 22581354
    [Abstract] [Full Text] [Related]

  • 7. Giant cell tumour of bone in the denosumab era.
    van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H.
    Eur J Cancer; 2017 May 01; 77():75-83. PubMed ID: 28365529
    [Abstract] [Full Text] [Related]

  • 8. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
    Stagner AM, Sajed DP, Nielsen GP, Ebb DH, Faquin WC, Chebib I, Rivera MN, Ting DT, Resnick CM, Peacock ZS, Kaban LB, Deshpande V.
    Am J Surg Pathol; 2019 Jun 01; 43(6):819-826. PubMed ID: 30998511
    [Abstract] [Full Text] [Related]

  • 9. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE.
    Spine J; 2024 Jun 01; 24(6):1056-1064. PubMed ID: 38301904
    [Abstract] [Full Text] [Related]

  • 10. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
    Goto Y, Furuno Y, Kawabe T, Ohwada K, Tatsuzawa K, Sasajima H, Hashimoto N.
    J Neurosurg; 2017 Feb 01; 126(2):431-434. PubMed ID: 27177173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme.
    Erdogan KE, DevecI MA, Paydas S, Gonlusen G.
    Pol J Pathol; 2016 Feb 01; 67(4):392-397. PubMed ID: 28547968
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base.
    Sekar A, Rudrappa S, Gopal S, Ghosal N, Gupta V, Ts L.
    World Neurosurg; 2018 Nov 01; 119():97-102. PubMed ID: 30075260
    [Abstract] [Full Text] [Related]

  • 17. Denosumab: a new treatment option for giant cell tumor of bone.
    Lewin J, Thomas D.
    Drugs Today (Barc); 2013 Nov 01; 49(11):693-700. PubMed ID: 24308016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.